Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress

被引:59
作者
Brandl, Andre [1 ]
Wagner, Tobias [1 ]
Uhlig, Katharina M. [1 ]
Knauer, Shirley K. [2 ]
Stauber, Roland H. [3 ]
Melchior, Frauke [4 ]
Schneider, Guenter [5 ]
Heinzel, Thorsten [1 ]
Kraemer, Oliver H. [1 ]
机构
[1] Univ Jena, Inst Biochem & Biophys, Dept Biochem, Ctr Mol Biomed, D-07745 Jena, Germany
[2] Univ Duisburg Essen, Ctr Med Biotechnol, D-45141 Essen, Germany
[3] Univ Hosp Mainz, Mol & Cellular Oncol Mainz Screening Ctr, D-55101 Mainz, Germany
[4] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany
[5] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, D-81675 Munich, Germany
关键词
acetylation; apoptosis; HDAC2; p53; SUMO; IN-VITRO; DNA-DAMAGE; GENE-EXPRESSION; CANCER-CELLS; ACETYLATION; TRANSCRIPTION; SUMO; VIVO; P21; INHIBITION;
D O I
10.1093/jmcb/mjs013
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Histone deacetylase 2 (HDAC2) is relevant for homeostasis and plays a critical role in gastrointestinal cancers. Here, we report that post-translational modification of endogenous HDAC2 with small ubiquitin-related modifier 1 (SUMO1) is a new regulatory switch for the tumor suppressor p53. Sumoylation of HDAC2 at lysine 462 allows binding of HDAC2 to p53. Moreover, sumoylated HDAC2 is a previously not recognized biologically relevant site-specific deacetylase for p53. Deacetylation of p53 at lysine 320 by sumoylated HDAC2 blocks recruitment of p53 into promoter-associated complexes and p53-dependent expression of genes for cell cycle control and apoptosis. Thereby, catalytically active sumoylated HDAC2 restricts p53 functions and attenuates DNA damage-induced apoptosis. Genotoxic stress evokes desumoylation of HDAC2, enabling p53-dependent gene expression. Our data show a new molecular mechanism involving a dynamically controlled HDAC2-sumoylation/p53-acetylation switch that regulates cell fate decisions following genotoxic stress.
引用
收藏
页码:284 / 293
页数:10
相关论文
共 45 条
[1]
STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line [J].
Baus, D. ;
Nonnenmacher, F. ;
Jankowski, S. ;
Doering, C. ;
Braeutigam, C. ;
Frank, M. ;
Hansmann, M-L ;
Pfitzner, E. .
LEUKEMIA, 2009, 23 (10) :1885-1893
[2]
Transcriptional Regulation by p53 [J].
Beckerman, Rachel ;
Prives, Carol .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (08) :a000935
[3]
Histone deacetylases: salesmen and customers in the post-translational modification market [J].
Brandl, Andre ;
Heinzel, Thorsten ;
Kraemer, Oliver H. .
BIOLOGY OF THE CELL, 2009, 101 (04) :193-205
[4]
p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315
[5]
Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[6]
How many mutant p53 molecules are needed to inactivate a tetramer? [J].
Chan, WM ;
Siu, WY ;
Lau, A ;
Poon, RYC .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (08) :3536-3551
[7]
Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients [J].
Chang, Hao-Hueng ;
Chiang, Chun-Pin ;
Hung, Hsin-Chia ;
Lin, Chiao-Ying ;
Deng, Yi-Ting ;
Kuo, Mark Yen-Ping .
ORAL ONCOLOGY, 2009, 45 (07) :610-614
[8]
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage [J].
Chao, Connie ;
Wu, Zhiqun ;
Mazur, Sharlyn J. ;
Borges, Helena ;
Rossi, Matteo ;
Lin, Tongxiang ;
Wang, Jean Y. J. ;
Anderson, Carl W. ;
Appella, Ettore ;
Xu, Yang .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (18) :6859-6869
[9]
Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells [J].
Fakhry, Hussein ;
Miyamoto, Tsutomu ;
Kashima, Hiroyasu ;
Suzuki, Akihisa ;
Ke, He ;
Konishi, Ikuo ;
Shiozawa, Tanri .
HUMAN PATHOLOGY, 2010, 41 (06) :848-858
[10]
HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA [J].
Fritsche, P. ;
Seidler, B. ;
Schueler, S. ;
Schnieke, A. ;
Goettlicher, M. ;
Schmid, R. M. ;
Saur, D. ;
Schneider, G. .
GUT, 2009, 58 (10) :1399-1409